AED 20m Al Jalila gift pushes 116-bed Hamdan Bin Rashid Cancer Hospital toward 2026

Al Jalila Foundation secured AED 20 million from Easa Saleh Al Gurg Charity Foundation for engineering systems at Hamdan Bin Rashid Cancer Hospital, a 116-bed Dubai Health oncology facility due to open in 2026.

For hospital owners, COOs and CFOs, the donation matters because it funds the operating backbone of Dubai Health's first integrated cancer care facility. The hospital will sit under Dubai Health, while licensing and operating standards in Dubai remain with the Dubai Health Authority (DHA). The market signal is specific: Dubai is adding publicly backed oncology capacity with ambulatory care, inpatient beds and research space on one campus.

What the AED 20 million funds

The agreement was signed at Al Jalila Foundation by Dr Amer Al Zarooni, CEO of Al Jalila Foundation, and Easa Al Gurg, Group CEO of Al Gurg Group, according to Gulf News. The money is earmarked for engineering systems tied to uptime, evacuation, fire safety and continuity of care before the 2026 opening.

• Low-voltage switchgear panels for electrical distribution.
• Fire alarm systems for life-safety compliance.
• Voice evacuation systems for emergency response.
• Central battery systems for backup power.

Scientechnic and Al Gurg Automation & Controls, both part of Al Gurg Group, will deliver design, supply, testing and commissioning for the hospital, Gulf News reported. That links the philanthropic gift to named vendors and to pre-opening work that hospital COOs usually treat as high risk before first patient intake.

Why oncology operators should watch

Stantec, the design firm appointed in 2024, said Hamdan Bin Rashid Cancer Hospital covers 603,000 square feet and is planned to include 50 clinics, 30 clinical trial areas, 60 infusion rooms, 10 urgent care rooms, 5 radiotherapy rooms and 116 inpatient beds.

Those figures give private oncology operators a practical benchmark. A facility with 60 infusion rooms can take on a large outpatient chemotherapy load. A campus with 30 clinical trial areas can move physicians, sponsors and patients toward a Dubai Health research channel. Private hospitals should review referral pathways, tumour boards, day-care infusion quality and payer contracting before the 2026 opening.

The project also sits inside a wider UAE regulator split. DHA sets Dubai's operating context. The Department of Health - Abu Dhabi (DOH) oversees Abu Dhabi and Al Ain. The Ministry of Health and Prevention (MOHAP) regulates the Northern Emirates. Operators with multi-emirate footprints should compare oncology service lines across all 3 systems, especially for clinical trials, licensing and patient transfer protocols.

What to track before opening

The AED 20 million contribution follows Al Jalila Foundation's reported AED 435 million in donations during 2025, also reported by Gulf News. The foundation said that funding supported 13 healthcare initiatives, 3,628 patients, 44 scholarships and 24 research grants.

For CFOs, the number to remember is 116 beds, because new inpatient oncology capacity can affect payer networks, physician recruitment costs and case-mix planning in 2026. For COOs, the immediate takeaway is readiness: fire systems, switchgear, battery systems and evacuation infrastructure are pre-opening dependencies. For medical directors, the 30 clinical trial areas may affect where complex cases are referred once Hamdan Bin Rashid Cancer Hospital starts accepting patients.

The next market marker is operational commissioning before the hospital opens to patients in 2026. DHA approvals, Dubai Health staffing plans and vendor handover milestones will show whether Hamdan Bin Rashid Cancer Hospital enters the market through phased services or a wider oncology launch.